Radioimmunotherapy Market Size, Share, Growth, and Industry Analysis, By Type (Beta-emitting and Targeted Alpha Therapy), By Application (Solid Tumor and Non-Hodgkin Lymphoma), Regional Insights and Forecast From 2025 To 2033

Detailed TOC of Global Radioimmunotherapy Market 2023 by Company, Regions, Type and Application, Forecast to 2033

1. 1 Market Overview
   1. Product Overview and Scope of Radioimmunotherapy
   2. Market Estimation Caveats and Base Year
   3. Classification of Radioimmunotherapy by Type
      1. Overview: Global Radioimmunotherapy Market Size by Type: 2018 Versus 2025 Versus 2033
      2. Global Radioimmunotherapy Consumption Value Market Share by Type in 2025
      3. Beta-emitting
      4. Targeted Alpha Therapy
   4. Global Radioimmunotherapy Market by Application
      1. Overview: Global Radioimmunotherapy Market Size by Application: 2018 Versus 2025 Versus 2033
      2. Solid Tumor
      3. Non Hodgkin Lymphoma
   5. Global Radioimmunotherapy Market Size & Forecast
   6. Global Radioimmunotherapy Market Size and Forecast by Region
      1. Global Radioimmunotherapy Market Size by Region: 2018 VS 2025 VS 2033
      2. Global Radioimmunotherapy Market Size by Region, (2018-2033)
      3. North America Radioimmunotherapy Market Size and Prospect (2018-2033)
      4. Europe Radioimmunotherapy Market Size and Prospect (2018-2033)
      5. Asia-Pacific Radioimmunotherapy Market Size and Prospect (2018-2033)
      6. South America Radioimmunotherapy Market Size and Prospect (2018-2033)
      7. Middle East and Africa Radioimmunotherapy Market Size and Prospect (2018-2033)
2. Company Profiles
   1. Bayer
      1. Bayer Details
      2. Bayer Major Business
      3. Bayer Radioimmunotherapy Product and Solutions
      4. Bayer Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2023)
      5. Bayer Recent Developments and Future Plans
   2. Novartis
      1. Novartis Details
      2. Novartis Major Business
      3. Novartis Radioimmunotherapy Product and Solutions
      4. Novartis Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2023)
      5. Novartis Recent Developments and Future Plans
   3. Lantheus
      1. Lantheus Details
      2. Lantheus Major Business
      3. Lantheus Radioimmunotherapy Product and Solutions
      4. Lantheus Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2023)
      5. Lantheus Recent Developments and Future Plans
   4. Aurobindo Pharma
      1. Aurobindo Pharma Details
      2. Aurobindo Pharma Major Business
      3. Aurobindo Pharma Radioimmunotherapy Product and Solutions
      4. Aurobindo Pharma Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2023)
      5. Aurobindo Pharma Recent Developments and Future Plans
   5. Mundipharma
      1. Mundipharma Details
      2. Mundipharma Major Business
      3. Mundipharma Radioimmunotherapy Product and Solutions
      4. Mundipharma Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2023)
      5. Mundipharma Recent Developments and Future Plans
   6. China Isotope & Radiation
      1. China Isotope & Radiation Details
      2. China Isotope & Radiation Major Business
      3. China Isotope & Radiation Radioimmunotherapy Product and Solutions
      4. China Isotope & Radiation Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2023)
      5. China Isotope & Radiation Recent Developments and Future Plans
   7. Curium Pharmaceuticals
      1. Curium Pharmaceuticals Details
      2. Curium Pharmaceuticals Major Business
      3. Curium Pharmaceuticals Radioimmunotherapy Product and Solutions
      4. Curium Pharmaceuticals Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2023)
      5. Curium Pharmaceuticals Recent Developments and Future Plans
   8. Gilead Sciences
      1. Gilead Sciences Details
      2. Gilead Sciences Major Business
      3. Gilead Sciences Radioimmunotherapy Product and Solutions
      4. Gilead Sciences Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2023)
      5. Gilead Sciences Recent Developments and Future Plans
   9. Clarity Pharmaceuticals
      1. Clarity Pharmaceuticals Details
      2. Clarity Pharmaceuticals Major Business
      3. Clarity Pharmaceuticals Radioimmunotherapy Product and Solutions
      4. Clarity Pharmaceuticals Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2023)
      5. Clarity Pharmaceuticals Recent Developments and Future Plans
   10. Curasight
       1. Curasight Details
       2. Curasight Major Business
       3. Curasight Radioimmunotherapy Product and Solutions
       4. Curasight Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2023)
       5. Curasight Recent Developments and Future Plans
   11. Nordic Nanovector
       1. Nordic Nanovector Details
       2. Nordic Nanovector Major Business
       3. Nordic Nanovector Radioimmunotherapy Product and Solutions
       4. Nordic Nanovector Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2023)
       5. Nordic Nanovector Recent Developments and Future Plans
   12. Philogen
       1. Philogen Details
       2. Philogen Major Business
       3. Philogen Radioimmunotherapy Product and Solutions
       4. Philogen Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2023)
       5. Philogen Recent Developments and Future Plans
   13. RadioMedix
       1. RadioMedix Details
       2. RadioMedix Major Business
       3. RadioMedix Radioimmunotherapy Product and Solutions
       4. RadioMedix Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2023)
       5. RadioMedix Recent Developments and Future Plans
   14. Telix Pharmaceuticals
       1. Telix Pharmaceuticals Details
       2. Telix Pharmaceuticals Major Business
       3. Telix Pharmaceuticals Radioimmunotherapy Product and Solutions
       4. Telix Pharmaceuticals Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2023)
       5. Telix Pharmaceuticals Recent Developments and Future Plans
   15. Orano Med
       1. Orano Med Details
       2. Orano Med Major Business
       3. Orano Med Radioimmunotherapy Product and Solutions
       4. Orano Med Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2023)
       5. Orano Med Recent Developments and Future Plans
   16. Actinium Pharmaceuticals
       1. Actinium Pharmaceuticals Details
       2. Actinium Pharmaceuticals Major Business
       3. Actinium Pharmaceuticals Radioimmunotherapy Product and Solutions
       4. Actinium Pharmaceuticals Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2023)
       5. Actinium Pharmaceuticals Recent Developments and Future Plans
   17. Y-mAbs Therapeutics
       1. Y-mAbs Therapeutics Details
       2. Y-mAbs Therapeutics Major Business
       3. Y-mAbs Therapeutics Radioimmunotherapy Product and Solutions
       4. Y-mAbs Therapeutics Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2023)
       5. Y-mAbs Therapeutics Recent Developments and Future Plans
   18. Fusion Pharmaceuticals
       1. Fusion Pharmaceuticals Details
       2. Fusion Pharmaceuticals Major Business
       3. Fusion Pharmaceuticals Radioimmunotherapy Product and Solutions
       4. Fusion Pharmaceuticals Radioimmunotherapy Revenue, Gross Margin and Market Share (2018-2023)
       5. Fusion Pharmaceuticals Recent Developments and Future Plans
3. Market Competition, by Players
   1. Global Radioimmunotherapy Revenue and Share by Players (2018-2023)
   2. Market Share Analysis (2025)
      1. Market Share of Radioimmunotherapy by Company Revenue
      2. Top 3 Radioimmunotherapy Players Market Share in 2025
      3. Top 6 Radioimmunotherapy Players Market Share in 2025
   3. Radioimmunotherapy Market: Overall Company Footprint Analysis
      1. Radioimmunotherapy Market: Region Footprint
      2. Radioimmunotherapy Market: Company Product Type Footprint
      3. Radioimmunotherapy Market: Company Product Application Footprint
   4. New Market Entrants and Barriers to Market Entry
   5. Mergers, Acquisition, Agreements, and Collaborations
4. Market Size Segment by Type
   1. Global Radioimmunotherapy Consumption Value and Market Share by Type (2018-2023)
   2. Global Radioimmunotherapy Market Forecast by Type (2024-2033)
5. Market Size Segment by Application
   1. Global Radioimmunotherapy Consumption Value Market Share by Application (2018-2023)
   2. Global Radioimmunotherapy Market Forecast by Application (2024-2033)
6. North America
   1. North America Radioimmunotherapy Consumption Value by Type (2018-2033)
   2. North America Radioimmunotherapy Consumption Value by Application (2018-2033)
   3. North America Radioimmunotherapy Market Size by Country
      1. North America Radioimmunotherapy Consumption Value by Country (2018-2033)
      2. United States Radioimmunotherapy Market Size and Forecast (2018-2033)
      3. Canada Radioimmunotherapy Market Size and Forecast (2018-2033)
      4. Mexico Radioimmunotherapy Market Size and Forecast (2018-2033)
7. Europe
   1. Europe Radioimmunotherapy Consumption Value by Type (2018-2033)
   2. Europe Radioimmunotherapy Consumption Value by Application (2018-2033)
   3. Europe Radioimmunotherapy Market Size by Country
      1. Europe Radioimmunotherapy Consumption Value by Country (2018-2033)
      2. Germany Radioimmunotherapy Market Size and Forecast (2018-2033)
      3. France Radioimmunotherapy Market Size and Forecast (2018-2033)
      4. United Kingdom Radioimmunotherapy Market Size and Forecast (2018-2033)
      5. Russia Radioimmunotherapy Market Size and Forecast (2018-2033)
      6. Italy Radioimmunotherapy Market Size and Forecast (2018-2033)
8. Asia-Pacific
   1. Asia-Pacific Radioimmunotherapy Consumption Value by Type (2018-2033)
   2. Asia-Pacific Radioimmunotherapy Consumption Value by Application (2018-2033)
   3. Asia-Pacific Radioimmunotherapy Market Size by Region
      1. Asia-Pacific Radioimmunotherapy Consumption Value by Region (2018-2033)
      2. China Radioimmunotherapy Market Size and Forecast (2018-2033)
      3. Japan Radioimmunotherapy Market Size and Forecast (2018-2033)
      4. South Korea Radioimmunotherapy Market Size and Forecast (2018-2033)
      5. India Radioimmunotherapy Market Size and Forecast (2018-2033)
      6. Southeast Asia Radioimmunotherapy Market Size and Forecast (2018-2033)
      7. Australia Radioimmunotherapy Market Size and Forecast (2018-2033)
9. South America
   1. South America Radioimmunotherapy Consumption Value by Type (2018-2033)
   2. South America Radioimmunotherapy Consumption Value by Application (2018-2033)
   3. South America Radioimmunotherapy Market Size by Country
      1. South America Radioimmunotherapy Consumption Value by Country (2018-2033)
      2. Brazil Radioimmunotherapy Market Size and Forecast (2018-2033)
      3. Argentina Radioimmunotherapy Market Size and Forecast (2018-2033)
10. Middle East & Africa
    1. Middle East & Africa Radioimmunotherapy Consumption Value by Type (2018-2033)
    2. Middle East & Africa Radioimmunotherapy Consumption Value by Application (2018-2033)
    3. Middle East & Africa Radioimmunotherapy Market Size by Country
       1. Middle East & Africa Radioimmunotherapy Consumption Value by Country (2018-2033)
       2. Turkey Radioimmunotherapy Market Size and Forecast (2018-2033)
       3. Saudi Arabia Radioimmunotherapy Market Size and Forecast (2018-2033)
       4. UAE Radioimmunotherapy Market Size and Forecast (2018-2033)
11. Market Dynamics
    1. Radioimmunotherapy Market Drivers
    2. Radioimmunotherapy Market Restraints
    3. Radioimmunotherapy Trends Analysis
    4. Porters Five Forces Analysis
       1. Threat of New Entrants
       2. Bargaining Power of Suppliers
       3. Bargaining Power of Buyers
       4. Threat of Substitutes
       5. Competitive Rivalry
    5. Influence of COVID-19 and Russia-Ukraine War
       1. Influence of COVID-19
       2. Influence of Russia-Ukraine War
12. Industry Chain Analysis
    1. Radioimmunotherapy Industry Chain
    2. Radioimmunotherapy Upstream Analysis
    3. Radioimmunotherapy Midstream Analysis
    4. Radioimmunotherapy Downstream Analysis
13. Research Findings and Conclusion
14. Appendix
    1. Methodology
    2. Research Process and Data Source
    3. Disclaimer